Christopher von Jako brings extensive leadership and experience in the global medical device market with a specific expertise in image guided technologies. He has spent over 20 years focusing on the development and commercialization of image-guided techniques to improve patient experience and outcomes. Most recently, Chris was the President and CEO of NeuroTherm, a medical device company that develops, manufactures, and markets state-of-the-art image-guided solutions for pain management. He successfully executed the divesture of NeuroTherm with his team in August 2014 to St. Jude Medical. Prior to that, Chris was the President of ActiViews, a privately held medical device company, which developed and marketed minimally invasive tools for Interventional Radiology. Prior to this, he worked in senior management positions at Integra LifeSciences, Covidien, Medtronic, and Radionics. Chris holds a PhD in Biomedical Sciences from the University of Pécs Medical School, a MS in Radiological Sciences and Technology from the department of Nuclear Engineering at the Massachusetts Institute of Technology, and a double BS degree in Physics and Mathematics from Bates College.

The NvisionVLE Imaging System is indicated for use as an imaging tool in the evaluation of human tissue microstructure, including esophageal tissue microstructure, by providing two-dimensional, cross-sectional, real-time depth visualization and may be used to mark areas of tissue.

The safety and effectiveness of this device for diagnostic analysis (i.e. differentiating normal versus specific abnormalities) in any tissue microstructure or specific disease has not been evaluated.